pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 1
KSP-1007
Ventilator Associated Pneumonia (VAP)
Sumitomo Pharma Co Ltd
Phase 2
KSQ-001
Head And Neck Squamous Cell Carcinoma (HNSC)
KSQ Therapeutics Inc
Phase 2
KSQ-004
Acral Lentiginous Melanoma
KSQ Therapeutics Inc
Phase 1
← prev
page 115 of 271
next →
Pain
89
Neurology
1
KST-6051
Metastatic Colorectal Cancer
$KG
Kestrel Group Ltd
Preclinical
KT-20610
Autism Spectrum Disorder (ASD)
Kingdom Therapeutics Ltd
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
Phase 2
KTP-001
Lumbar Hernia/Bleichner's Hernia
Teijin Pharma Ltd
Phase 1
KTX-2001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
K36 Therapeutics Inc
Phase 2
KUS-121
Retinal Artery Occlusion
Kyoto Drug Discovery & Development Co Ltd
Phase 1
KY-0118
Colorectal Cancer
Shanghai Keyi Pharmaceutical Technology Co Ltd
Preclinical
KY-0601
Colorectal Cancer
Novatim Immune Therapeutics (Zhejiang) Co Ltd
Preclinical
KY-0901
Bile Duct Cancer (Cholangiocarcinoma)
Novatim Immune Therapeutics (Zhejiang) Co Ltd
KYGEVVI
KYGEVVI (DOXECITINE)
no indication
UCB SA
Marketed
Kcentra
Kcentra ((coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C (human) + protein S (human)))
Bleeding And Clotting Disorders
CSL Behring LLC
Marketed
Kenalog
Kenalog (triamcinolone acetonide)
Atopic Dermatitis (Atopic Eczema)
Sun Pharmaceutical Industries Ltd
Phase 2
Ketamir-2
Chemotherapy Induced Peripheral Neuropathy
Miralogx LLC
Marketed
Ketotifen Fumarate Apotex
Ketotifen Fumarate
Allergic Conjunctivitis
Apotex Corp
Marketed
Kimyrsa
Kimyrsa (oritavancin [INN])
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Melinta Therapeutics LLC
Preclinical
Kindolor
Diabetic Neuropathy
Lohocla Research Corp
Marketed
Klaron
Sulfacetamide Sodium Oceanside (sulfacetamide sodium)
Acne Vulgaris
Bausch Health Americas Inc
Marketed
Klor-Con
Klor-Con (potassium chloride)
Hypokalemia
Upsher-Smith Laboratories LLC
Marketed
Kloxxado
Kloxxado (naloxone hydrochloride)
Acute Opioid Overdosage
Hikma Pharmaceuticals USA Inc
Marketed
Kovaltry
Kovaltry (antihemophilic factor (recombinant))
Hemophilia A (Factor VIII Deficiency)
Bayer HealthCare Pharmaceuticals Inc
Preclinical
Kuragenx
Neurotrophic Keratitis
Pandorum Technologies Pvt Ltd
Marketed
Kyleena
Kyleena (levonorgestrel)
Female Contraception
Bayer AG
Phase 1
L-130
Generalized Anxiety Disorder (GAD)
Cynaptec Pharmaceuticals Inc
Phase 2
L-Citrulline
Sickle Cell Disease With Vaso-Occlusive Crisis
Asklepion Pharmaceuticals LLC
LACOSAMIDE ORAL SOLUTION
LACOSAMIDE ORAL SOLUTION
no indication
ALKEM LABS LTD
LACRISERT
LACRISERT (HYDROXYPROPYL CELLULOSE)
no indication
BAUSCH AND LOMB INC
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER
LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE)
no indication
Baxter Healthcare Corp
